Post-discharge sequelae of Lassa fever survivors in Nigeria: an analysis of the LASCOPE prospective cohort.
Guichard, Eva, Juchet, Sylvain, Etafo, Ijeoma Chukwudumebi et al. · The Lancet. Infectious diseases · 2026 · DOI
Quick Summary
This study followed 882 people who recovered from Lassa fever (a serious viral infection) after hospital discharge to see what long-term symptoms they experienced. Most survivors felt better within about 3 weeks after leaving the hospital, with the most common lingering symptoms being tiredness, headaches, and difficulty with physical activity. The good news is that serious complications like hearing loss were rare, affecting only 2% of survivors.
Why It Matters
This study is relevant to ME/CFS research because it systematically characterizes post-viral fatigue and post-exertional malaise in a large cohort of viral infection survivors, conditions that closely mirror ME/CFS symptoms. Understanding the natural recovery trajectory and symptom patterns in another post-viral illness may inform mechanistic insights and therapeutic approaches for ME/CFS pathogenesis and long-term management.
Observed Findings
91% of 807 Lassa fever survivors achieved clinical remission with median time of 19 days post-discharge.
Asthenia was reported by 20% (158/804), headache by 18% (148/804), and post-exertional malaise by 15% (123/804) of survivors.
Hearing symptoms were reported by only 2% (17/804) of survivors, substantially lower than in previous studies.
Disease severity during acute infection did not affect time to clinical remission.
Post-discharge mortality was 1% (6/882 survivors).
Inferred Conclusions
Most Lassa fever survivors experience good recovery with rapid symptom resolution, suggesting that persistent post-viral sequelae may not be universal in this population.
Post-exertional malaise and asthenia represent the most prominent long-term symptoms in Lassa fever survivors, distinct from the hearing complications reported in earlier literature.
Objective diagnostic assessments are needed to accurately characterize the true burden of neurosensory and other post-discharge complications.
Remaining Questions
What are the underlying pathophysiological mechanisms driving post-exertional malaise and asthenia in Lassa fever survivors, and do they resemble ME/CFS mechanisms?
What is the duration of post-exertional malaise beyond the 60-day follow-up window, and do some patients develop chronic or relapsing symptoms?
What This Study Does Not Prove
This study does not prove that Lassa fever survivors and ME/CFS patients experience identical pathophysiology or recovery patterns, nor does it establish causative mechanisms for post-exertional malaise. The predominance of patient-reported symptoms without objective biomarkers or validated fatigue scales limits conclusions about the severity and pathological basis of symptoms. Additionally, the relatively short median follow-up period may not capture all delayed or chronic sequelae.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.